Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding - PubMed (original) (raw)
. 2003 May 30;278(22):20381-8.
doi: 10.1074/jbc.M300130200. Epub 2003 Mar 19.
Affiliations
- PMID: 12646557
- DOI: 10.1074/jbc.M300130200
Free article
Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding
Pierre Fechter et al. J Biol Chem. 2003.
Free article
Abstract
mRNAs are capped at their 5'-end by a unique cap structure containing N7-methyl guanine. Recognition of the cap structure is of paramount importance in some of the most central processes of gene expression as well as in some viral processes, such as priming of influenza virus transcription. The recent resolution of the structure of three evolutionary unrelated cap binding proteins, the vaccinia viral protein VP39, the eukaryotic translation factor eIF4E, and the nuclear cap-binding protein CBP20 showed that the recognition of the cap structure is achieved by the same general mechanism, i.e. by "sandwiching" of the N7-methyl guanine of the cap structure between two aromatic amino acid residues. The purpose of the present study was to test whether a similar cap recognition mechanism had independently evolved for the RNA polymerase of influenza virus. Combining in vivo and in vitro methods, we characterized two crucial aromatic amino acids, Phe363 and Phe404, in the PB2 subunit of the viral RNA polymerase that are essential for cap binding. The aromaticity of these two residues is conserved in influenza A, B, and C and even in the divergent Thogoto virus PB2 subunits. Thus, our results favor a similar mechanism of cap binding by the influenza RNA polymerase as in the evolutionary unrelated VP39, eIF4E, and CBP20.
Similar articles
- Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase.
Wakai C, Iwama M, Mizumoto K, Nagata K. Wakai C, et al. J Virol. 2011 Aug;85(15):7504-12. doi: 10.1128/JVI.02375-10. Epub 2011 May 18. J Virol. 2011. PMID: 21593178 Free PMC article. - Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.
Reguera J, Weber F, Cusack S. Reguera J, et al. PLoS Pathog. 2010 Sep 16;6(9):e1001101. doi: 10.1371/journal.ppat.1001101. PLoS Pathog. 2010. PMID: 20862319 Free PMC article. - Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit.
Xie L, Wartchow C, Shia S, Uehara K, Steffek M, Warne R, Sutton J, Muiru GT, Leonard VH, Bussiere DE, Ma X. Xie L, et al. J Biol Chem. 2016 Jan 1;291(1):363-70. doi: 10.1074/jbc.M115.693051. Epub 2015 Nov 11. J Biol Chem. 2016. PMID: 26559973 Free PMC article. - Recognition of mRNA cap structures by viral and cellular proteins.
Fechter P, Brownlee GG. Fechter P, et al. J Gen Virol. 2005 May;86(Pt 5):1239-1249. doi: 10.1099/vir.0.80755-0. J Gen Virol. 2005. PMID: 15831934 Review. - [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D. Hatakeyama D. Yakugaku Zasshi. 2017;137(2):205-214. doi: 10.1248/yakushi.16-00195. Yakugaku Zasshi. 2017. PMID: 28154333 Review. Japanese.
Cited by
- RNA Overwriting of Cellular mRNA by Cas13b-Directed RNA-Dependent RNA Polymerase of Influenza A Virus.
Ogasawara S, Ebashi S. Ogasawara S, et al. Int J Mol Sci. 2023 Jun 11;24(12):10000. doi: 10.3390/ijms241210000. Int J Mol Sci. 2023. PMID: 37373148 Free PMC article. - Role of RNA Polymerase II Promoter-Proximal Pausing in Viral Transcription.
Whelan M, Pelchat M. Whelan M, et al. Viruses. 2022 Sep 13;14(9):2029. doi: 10.3390/v14092029. Viruses. 2022. PMID: 36146833 Free PMC article. Review. - Equine Influenza Virus and Vaccines.
Oladunni FS, Oseni SO, Martinez-Sobrido L, Chambers TM. Oladunni FS, et al. Viruses. 2021 Aug 20;13(8):1657. doi: 10.3390/v13081657. Viruses. 2021. PMID: 34452521 Free PMC article. Review. - Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase.
Gregor J, Radilová K, Brynda J, Fanfrlík J, Konvalinka J, Kožíšek M. Gregor J, et al. Molecules. 2021 Feb 14;26(4):1007. doi: 10.3390/molecules26041007. Molecules. 2021. PMID: 33673017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous